1. Nestle approaches Bombay HC against FSSAI’s Maggi ban, hearing on Friday

Nestle approaches Bombay HC against FSSAI’s Maggi ban, hearing on Friday

The Food Safety and Standards Authority of India (FSSAI) issued an order last week banning all variants of Nestle India's Maggi noodles, terming them as "unsafe and hazardous" for human consumption.

By: | Mumbai | Updated: June 11, 2015 5:01 PM
nestle india

The Food Safety and Standards Authority of India (FSSAI) issued an order last week banning all variants of Nestle India’s Maggi noodles, terming them as “unsafe and hazardous” for human consumption. (Reuters)

Multinational Giant Nestle India Ltd on Thursday challenged in the Mumbai High Court the orders of food authorities banning nine variants of its instant product “Maggi” from the Indian market for being “hazardous” to public health and the plea will be heard on Friday.

The revision application (appeal against the impugned orders passed by authorities in Delhi and Maharashtra) was mentioned orally by the company’s counsel before a division bench of Justice V M Kanade and B P Colabawalla which posted it for hearing on Friday.

Read Also: Maggi effect: HUL to withdraw Knorr noodles as product not yet approved by FSSAI



The lawyer urged the court to hear the matter urgently as the company had suffered losses due to the food regulator’s orders which had asked Nestle India Ltd to withdraw and recall the products from the market with immediate effect after finding that they were “hazardous to public health due to presence of lead more than the permissible limits”.

Nestle urged the HC to quash the June 5 order of Delhi-based Food Safety and Standards Authority of India (FSSAI) and its Chief Executive Officer asking the company to withdraw and recall all its nine variants of Maggi from the market as they were unsafe and hazardous for human consumption.

The impugned orders also asked the company to stop production, processing, import, distribution and sale of their products with immediate effect, said Nestle.

Nestle also prayed for setting aside the impugned order of Commissioner of Food Safety, Government of Maharashtra, banning the production and sale of ‘Maggi’ products of the company in the State.

The company said the impugned orders do not comply with the mandatory provisions of section 34 of Food Safety and Standards Authority Act which deals with Emergency prohibition notices and orders. It said the orders were passed without any authority and without following due process of law.

The company also said the impugned orders were illegal, arbitrary and violative of the principles of Natural Justice as well as the Constitution of India.

For Updates Check Company News; follow us on Facebook and Twitter

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

  1. N
    Narendra M
    Jun 12, 2015 at 7:18 am
    (1) One wonders whether safety of food products can be a matter which can be decided by a court of law. Is it not a fact that food products sold by wayside vendors as also by many small and medium scale enterprises are rarely tested for safety? But if cases are filed against such delinquent vendors, they may drag on for years. (2) The Food and Drug Administration (FDA), which is supposed to ensure that safety standards are indeed followed, is simply not equipped to deal with the job of testing products sold by ready-to eat food vendors as also others whose number is quite huge in many metropolitan cities. (3) It is often claimed that ingredients used for manufacturing food products are themselves not very safe. Thus the w issue of food safety has to be looked at from a wider angle and there are no easy solutions. (4) It is worth mentioning here that a case filed against milk vendors for adulteration may take anything up to twenty years to be disposed off. Our judicial system is simply not ready to deal with such cases. (5) However, it is also true that big companies should not be allowed to take undue advantage of the existing scenario of poorly staffed FDA.

    Go to Top